Lamzede 10 mg/1
Velmanase alfa-tycv · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · Chiesi USA, Inc.
Lamzede is a injection, powder, lyophilized, for solution containing velmanase alfa-tycv at 10 mg/1, taken intravenous. Manufactured by Chiesi USA, Inc..
Key Facts
- Brand Name
- Lamzede
- Generic Name
- Velmanase alfa-tycv
- NDC Code (Product)
10122-180- Manufacturer
- Chiesi USA, Inc.
- Strength
- 10 mg/1
- Dosage Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Marketing Status
- Application #
- BLA761278
- Marketing Start
- 03/01/2023
Recall History
No Recall HistoryFrequently Asked Questions
What is Lamzede used for?
Lamzede contains Velmanase alfa-tycv. It is a injection, powder, lyophilized, for solution taken intravenous. Consult your doctor for specific uses.
Is Lamzede a controlled substance?
Lamzede is not classified as a controlled substance by the DEA.
What is the generic name for Lamzede?
The generic name for Lamzede is Velmanase alfa-tycv. There are no other listed brand versions of Velmanase alfa-tycv.
What is the NDC code for Lamzede 10 mg/1?
The NDC (National Drug Code) for Lamzede 10 mg/1 is 10122-180, listed by Chiesi USA, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)